Drug Type Synthetic peptide |
Synonyms |
Target |
Action agonists |
Mechanism MAS1L agonists(MAS1 proto-oncogene like, G protein-coupled receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | Israel | - |